Literature DB >> 17822750

Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasia.

Bryan Pham1, Nan Earle, Karen Rabel, Michele Follen, Michael E Scheurer.   

Abstract

INTRODUCTION: We compare the racial and ethnic demographics of our participants with the populations where our clinics are located (Texas and British Columbia) and investigate the reasons cited for participation.
METHODS: We compared the distribution of participants by race/ethnicity to numbers from the 2000 United States Census and the 2001 Census of Canada. Each participant recorded her reasons for enrolling in the trial in her own words. This information was then categorized for analysis. For participants who provided more than one reason for participation, their responses were weighted accordingly to sum 100% for each race. All analyses were performed using SPSS v12.0 (SPSS, Chicago).
RESULTS: In all, 1850 women participated in the study. Except for Asians in the Vancouver population and Native Americans in both populations, all minorities were recruited in proportions in excess of their respective proportions in the general population. Distinct differences in the reasons for participating between sites were noted. Houston patients were more likely to cite concern for one's own health as a reason for participating. On the other hand, Vancouver patients were more likely to cite helping others. This trend was found in both the screening and diagnostic populations.
CONCLUSIONS: We attribute our success in recruiting minorities to community outreach, our multicultural staff, and efforts to provide uniform care at all sites.

Entities:  

Mesh:

Year:  2007        PMID: 17822750      PMCID: PMC2978042          DOI: 10.1016/j.ygyno.2007.07.063

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Recruitment and retention of minority women in cancer screening, prevention, and treatment trials.

Authors:  D R Brown; M N Fouad; K Basen-Engquist; G Tortolero-Luna
Journal:  Ann Epidemiol       Date:  2000-11       Impact factor: 3.797

Review 2.  Why patients don't take part in cancer clinical trials: an overview of the literature.

Authors:  K Cox; J McGarry
Journal:  Eur J Cancer Care (Engl)       Date:  2003-06       Impact factor: 2.520

3.  Technology assessment in medicine.

Authors:  B Littenberg
Journal:  Acad Med       Date:  1992-07       Impact factor: 6.893

4.  Involving minority and underrepresented women in clinical trials: the National Centers of Excellence in Women's Health.

Authors:  M Killien; J A Bigby; V Champion; E Fernandez-Repollet; R D Jackson; M Kagawa-Singer; K Kidd; M J Naughton; M Prout
Journal:  J Womens Health Gend Based Med       Date:  2000-12

Review 5.  Optical spectroscopy for detection of neoplasia.

Authors:  Konstantin Sokolov; Michele Follen; Rebecca Richards-Kortum
Journal:  Curr Opin Chem Biol       Date:  2002-10       Impact factor: 8.822

Review 6.  Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials.

Authors:  Gabriel Y Lai; Tiffany L Gary; Jon Tilburt; Shari Bolen; Charles Baffi; Renee F Wilson; Mollie W Howerton; M Chris Gibbons; Teerath Peter Tanpitukpongse; Neil R Powe; Eric B Bass; Jean G Ford
Journal:  Clin Trials       Date:  2006       Impact factor: 2.486

7.  Participant recruitment and motivation for participation in optical technology for cervical cancer screening research trials.

Authors:  Olga M Shuhatovich; Mathilde P Sharman; Yvette N Mirabal; Nan R Earle; Michele Follen; Karen Basen-Engquist
Journal:  Gynecol Oncol       Date:  2005-09-06       Impact factor: 5.482

Review 8.  Optical technologies for cervical neoplasia: update of an NCI program project grant.

Authors:  Michele Follen; Stacy Crain; Calum MacAulay; Karen Basen-Engquist; Scott B Cantor; Dennis Cox; E Neely Atkinson; Nick MacKinnon; Martial Guillaud; Rebecca Richards-Kortum
Journal:  Clin Adv Hematol Oncol       Date:  2005-01

9.  Patients' attitudes and comfort levels regarding medical students' involvement in obstetrics-gynecology outpatient clinics.

Authors:  M B Hartz; J R Beal
Journal:  Acad Med       Date:  2000-10       Impact factor: 6.893

10.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

View more
  4 in total

1.  Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Authors:  Timon P H Buys; Scott B Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; José-Miguel Yamal; J Robert Beck; Michael E Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F Adewole; Calum MacAulay; Michele Follen
Journal:  Gend Med       Date:  2011-09-22

2.  Studying cancer in minorities: a look at the numbers.

Authors:  Sara H Olson; Tracy M Layne; Jennifer A Simon; Emmy Ludwig; Eileen O'Reilly; Peter J Allen; Robert C Kurtz
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

3.  Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy.

Authors:  Scott B Cantor; Jose-Miguel Yamal; Martial Guillaud; Dennis D Cox; E Neely Atkinson; John L Benedet; Dianne Miller; Thomas Ehlen; Jasenka Matisic; Dirk van Niekerk; Monique Bertrand; Andrea Milbourne; Helen Rhodes; Anais Malpica; Gregg Staerkel; Shahla Nader-Eftekhari; Karen Adler-Storthz; Michael E Scheurer; Karen Basen-Engquist; Eileen Shinn; Loyd A West; Anne-Therese Vlastos; Xia Tao; J Robert Beck; Calum Macaulay; Michele Follen
Journal:  Int J Cancer       Date:  2010-11-09       Impact factor: 7.396

4.  The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.

Authors:  Marylou Cárdenas-Turanzas; Graciela M Nogueras-Gonzalez; Michael E Scheurer; Karen Adler-Storthz; J L Benedet; J Robert Beck; Michele Follen; Scott B Cantor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.